The presence of immune memory at pathogen-entry sites is a prerequisite for protection. Nevertheless, the mechanisms that warrant immunity at peripheral interfaces are not understood. Here we show that the nonclassical major histocompatibility complex (MHC) class I molecule thymus leukemia antigen (TL), induced on dendritic cells interacting with CD8aa on activated CD8ab + T cells, mediated affinity-based selection of memory precursor cells. Furthermore, constitutive expression of TL on epithelial cells led to continued selection of mature CD8ab + memory T cells. The memory process driven by TL and CD8aa was essential for the generation of CD8ab + memory T cells in the intestine and the accumulation of highly antigen-sensitive CD8ab + memory T cells that form the first line of defense at the largest entry port for pathogens.
A r t i c l e s
A hallmark of immune memory is that repeated infections are met with accelerated and enhanced protective immunity 1 . Furthermore, unlike naive T lymphocytes or central memory T cells, which reside in lymphoid tissues, some antigen-experienced T cells gain the ability to persist long term as effector memory T cells (T EM cells) in nonlymphoid tissues such as the intestine [2] [3] [4] [5] . Central memory T cells, which respond with robust clonal expansion, are effective at protecting against infections by pathogens that replicate systemically 6 , but they are probably inadequate to prevent the transmission of viruses (including human immunodeficiency virus (HIV)) or intracellular bacteria that penetrate the mucosal epithelia 3, 7 . Effective resistance to the transmission of such pathogens requires the presence of local, antigen-specific T EM cells before rechallenge 7 . Therefore, strategies aimed at inducing a powerful protective immune response that also warrants the formation of preexisting mucosal antigen-specific T EM cells are considered an essential goal of successful vaccination.
Listeria monocytogenes, a Gram-positive intracellular pathogen of human and other mammals, including mice, is a food-borne pathogen; after ingestion and uptake by phagocytic cells, such as monocytes and dendritic cells (DCs), L. monocytogenes disseminate from the intestine into the bloodstream and spread to various systemic tissues such as the liver 8 . In humans, ingested L. monocytogenes may cause listeriosis because of its ability to also infect nonphagocytic cells, such as intestinal epithelial cells, through interaction of internalin (expressed by L. monocytogenes) and human E-cadherin (expressed on the basolateral pole of the enterocytes) 9 . In contrast, mice infected orally with L. monocytogenes do not develop listeriosis because of the inability of internalin to interact with mouse E-cadherin. Instead, mice clear the ingested bacteria via an effective CD8-dependent protective immune response, although bacteria that cross the mucosal barrier can spread to the liver and other organs via the blood, as can happen in humans 8 . Such observations have important implications for immunization strategies and indicate that the presence of local preexisting mucosal immunity might be key for the induction of effective protective immunity to ingested pathogens. Despite that, however, most knowledge of immune memory has been gained from model systems that use systemic immunization routes and memory generation in lymphoid tissues. Such preexisting immunity might be highly effective in combating systemic infection but is probably inadequate for controlling pathogens that invade the body via the oral route. Because of the protective mucosal CD8-mediated anti-L. monocytogenes response in mice and because of the emergence of genetically manipulated avirulent, attenuated strains of wild-type and recombinant L. monocytogenes deficient in ActA protein (which is essential for the motility and spreading of L. monocytogenes; ActA − L. monocytogenes) as important vectors for vaccination 8, 10, 11 , immunization of mice with L. monocytogenes introduced via the oral route represents an optimal approach with which to examine the mechanisms and conditions that lead to the generation of preexisting mucosal immune memory.
Homodimers of CD8 (CD8αα) induced on activated CD8αβ + T cells, which maintain expression of CD8αβ, mark those primary effector cells that have a propensity to differentiate into memory cells 12 . In mice, the epithelium of the intestine is greatly enriched for memory CD8αβ + T cells that coexpress CD8αα 13 . Thymus leukemia antigen (TL) is a high-affinity ligand for CD8αα 14 . TL is a nonclassical, nonpolymorphic major histocompatibility complex (MHC) class I molecule encoded on chromosome 17 in the H2-T region. This locus has undergone genetic rearrangements to produce at least two functional alleles, H2-T3 (in H-2 b mouse strains such as C57BL/6 (B6)) and H2-T18 (in H-2 d mouse strains such as BALB/c). Despite its name, TL is constitutively expressed on intestinal epithelial cells that are adjacent to the CD8αα + T cells 15, 16 . Such findings suggest a role for TL in the accumulation of mucosal CD8αα + CD8αβ + memory T cells; however, the mechanisms that drive the CD8αα-dependent generation of mucosal immune memory remain unknown.
Through the use of a model of oral infection with L. monocytogenes to elicit a CD8-driven protective immune response initiated at the mucosal entry site, we define here an affinity-based selection mechanism controlled by TL expression. This was induced on antigenpresenting cells (APCs) and led to the survival and differentiation of high-affinity, CD8αα + CD8αβ + memory precursor cells. Furthermore, constitutive expression of TL on the epithelium of the intestine continued to impose selection pressure, which contributed to the affinity maturation of the resident mucosal CD8αβ + T EM cells.
RESULTS

TL is not required for memory CD8ab + T cells
Among the MHC class I molecules encoded by the mouse genome, TL is distinguished because it has a particularly high affinity for CD8αα mediated by three unique amino acid alterations in the highly conserved membrane-proximal α3 domain of its MHC class I heavy chain 17 . To assess if TL, the most likely physiological ligand for CD8αα in vivo 12 , also has a role in the generation of CD8αβ + effector memory cells, we analyzed the differentiation of CD8αβ + memory T cells in mice with deletion of the gene encoding TL (called 'TL − mice' here) 18 . We assessed the generation of ovalbumin (OVA)-specific CD8αβ + memory T cells in the spleens of TL − mice infected orally with L. monocytogenes that express OVA antigen (LM-OVA) and found that the absence of TL did not impair but instead enhanced the generation of these cells (Fig. 1a) . We observed a similar effect in the epithelium of the intestine of these mice when we analyzed intraepithelial lymphocytes (IELs; Fig. 1a) . Likewise, the transfer of naive OT-I T cells transgenic for the expression of monoclonal T cell antigen receptor (TCR) specific for the OVA peptide SIINFEKL (amino acids 257-264) and H-2K b into wild-type or TL − recipient (Fig. 1b) . Those observations were consistent with published data of mice with transgenic expression of singlechain MHC class I on a β 2 -microglobulin-deficient background also indicating that in the absence of TL, normal or slightly enhanced memory forms in response to viral infection 19 . Together the data show that whereas CD8αα promotes the memory differentiation of CD8αβ + effector T cells 12 , its high-affinity ligand TL seems to inhibit this process.
TL expressed on APCs kills primed CD8ab + T cells TL has a restricted pattern of expression 20 that includes induction on APCs, such as DCs, in addition to expression on epithelial cells 12 .
The greater abundance of memory CD8αβ + T cells seen in the absence of TL in TL − mice suggested that under normal conditions, TL expression on subsets of priming DCs might negatively influence the survival or differentiation of CD8αβ + memory precursor cells.
To assess this possibility, we analyzed the effect of constitutive TL expression during priming through the use of TL-transgenic mice that express an allelic form of the gene encoding TL under control of the promoter of the gene encoding the MHC class I molecule H-2D. In contrast to the outcome in TL − hosts, transferred OT-I T cells primed in vivo in TL-transgenic recipient mice orally infected with LM-OVA failed to generate or sustain immune memory either locally, in the intestine, or systemically, in the spleen or liver ( Fig. 1c and Supplementary Fig. 1 ). Moreover, OT-I T cells primed systemically in vivo with TL-transgenic bone marrow DCs loaded with SIINFEKL transferred failed to generate memory cells in the spleens of wild-type hosts (Fig. 1d) . Similarly, OT-I cells initially primed in vitro by APCs transfected to express TL did not generate memory cells after adoptive transfer (Fig. 1d) . These data indicated that TL expression on APCs interfered with the survival and memory programming of primary CD8αβ + effector cells. Under steady-state conditions, resting splenic DCs normally do not have detectable expression of TL surface protein, although some induce it after activation 12 . However, analysis of various DC subsets indicated that in contrast to splenic DCs, a subset of mesenteric lymph node (mLN) DCs had constitutively low expression of TL. This TL + subset had the phenotype of mature migratory DCs (high expression of MHC class II, CD11c + and CD103 + CCR7 + ; Supplementary  Fig. 2a ) also typical of those DCs that directed retinoic acid-based induction of gut-homing receptors on the T cells they primed 21 ( Fig. 1e and Supplementary Fig. 2b ). The expression of TL on these mucosal DCs was further upregulated during priming and was considerably enhanced in response to innate immune stimuli such as CpG oligodeoxynucleotides (Fig. 1f ) . These observations indicated that naive T cells responding in vivo to gut-derived antigens were primed in the context of TL expressed by the migratory DCs and upregulated considerably under inflammatory conditions.
TL kills T cells via the receptor Fas
Although TL has structural features characteristic of MHC class I molecules, it does not function as a typical antigen-presenting molecule. The narrow distance between the α-helices that form the boundaries of the antigen-binding groove do not permit peptide binding and presentation by TL 22 , and therefore TL fails to engage with the αβ TCR. Nevertheless, the high degree of conserved sequence in the α3 domain allows TL to interact with the coreceptor CD8αβ despite the exclusion of TL from the TCR activation complex 14 . A similar interaction of soluble HLA class I molecules with the CD8αβ TCR coreceptor, separately from TCR ligation, has been shown to lead to cell death induced by the tumor necrosis factor receptor superfamily member 6 Fas (CD95) and its ligand [23] [24] [25] [26] . To determine if the interaction of TL with CD8αβ on activated T cells might also lead to cell death, we monitored the survival of naive and activated CD8αβ + cells in the presence of constitutive TL expression in TL-transgenic hosts. Whereas naive donor cells survived similarly in wild-type or TL-transgenic mice, activated CD8αβ + OT-I cells survived only in wild-type hosts but not in TL-transgenic hosts (Fig. 2a) , which supported the proposal that TL-induced cell death targeted activated CD8αβ + T cells. However, activated Fas-deficient (Fas lpr/lpr ) CD8αβ + donor T cells were not deleted from TL-transgenic recipient mice (Fig. 2b) , which provided evidence that similar to the reported cell death mediated by soluble HLA-G 23, 24 , TL-induced cell death also involved the death pathway mediated by Fas and its ligand.
Activation-induced CD8aa 'rescues' CD8ab + effector T cells In contrast to CD8αβ, CD8αα does not function as a TCR coreceptor and, similar to TL, CD8αα also does not participate directly in the TCR activation complex 27, 28 . However, whereas TL induces the death of activated CD8αβ + T cells, CD8αα, which has higher affinity for TL than does CD8αβ 14 , promotes the survival of CD8αβ + effector cells 12 , which suggests that activation-induced CD8αα might interfere with TL-induced cell death. To assess this, we compared the survival and memory differentiation of CD8αβ + effector T cells in the presence or absence of CD8αα. Because of deletion of the enhancer region I in the promoter of the gene encoding CD8α 29 , OT-I CD8αβ + donor cells on the E8 I -deficient background (called '∆E8 I OT-I CD8αβ + T cells' here) do not induce detectable amounts of activation-dependent CD8αα 12 . In vitro, ∆E8 I OT-I CD8αβ + T cells primed by SIINFEKLloaded mLN DCs, which expressed TL (Fig. 1e) , underwent more activation-induced death than did their counterparts primed by splenic DCs (Fig. 3a) . However, similar enhanced death of ∆E8 I OT-I CD8αβ + T cells primed by SIINFEKL-loaded mLN DCs isolated from TL − mice was not induced by those mucosal APCs (Fig. 3a) . Furthermore, similar to published results showing impaired splenic memory generation by ∆E8 I CD8αβ + T cells in response to intraperitoneal infection with lymphocytic choriomeningitis virus (LCMV) 12 , ∆E8 I OT-I CD8αβ + donor cells primed in vivo with LM-OVA via the oral route also failed to generate detectable memory cells in the spleens or intestines of wild-type recipient mice (Fig. 3b) . In contrast, another published study using the same systemic LCMV-immunization approach has shown that ∆E8 I CD8αβ + T cells do generate systemic memory 30 . However, there was substantial downregulation of CD8αβ during the initial priming phase in that study 30 , which was not seen on either wild-type CD8αβ + T cells or the LCMVprimed ∆E8 I CD8αβ + T cells in the other study noted above 12 . We considered the possibility that a difference in the strength of the LCMV viral stock might have caused downregulation of CD8αβ and effects on survival similar to those mediated by activationinduced CD8αα on normal wild-type CD8αβ + T cells. To investigate this, we assessed whether, in the model used here, the memory response of ∆E8 I OT-I CD8αβ + T cells was altered in mice primed systemically with LM-OVA introduced intravenously, a route that induces a much more potent response than does the oral route 8 . In contrast to oral immunization, systemic priming of the ∆E8 I OT-I CD8αβ + T cells with LM-OVA resulted in a distinct memory response in the spleen and intestine similar to that of wild-type OT-I cells (Fig. 3c) . Furthermore, similar to the study discussed above 30 , CD8αβ was downregulated substantially during the potent priming of ∆E8 I OT-I CD8αβ + T cells activated via the intravenous route, whereas such downregulation did not occur in ∆E8 I OT-I CD8αβ + T cells primed via the oral route (Fig. 3d) . Although activationinduced downregulation of CD8αβ could explain the survival of ∆E8 I OT-I CD8αβ + T cells during systemic priming, it does not explain the long-term survival of these cells in the intestine, where TL is constitutively expressed on intestinal epithelial cells. To further investigate this, we analyzed the CD8αβ expression of ∆E8 I OT-I CD8αβ + memory T cell subsets in the spleen and the intestine. Notably, whereas ∆E8 I OT-I CD8αβ + memory cells in the periphery expressed normal amounts of CD8αβ, memory ∆E8 I OT-I CD8αβ + IELs that persisted in the presence of TL expressed much less CD8αβ (Fig. 3e) . These results indicated that the mechanism of TL-induced cell death continuously and selectively shapes the repertoire of the memory cells that accumulate at the mucosal site of the intestine. In support of that hypothesis, in the absence of TL expression in the intestine of TL − hosts, as with systemic priming, there was no difference in the efficiency of memory formation in the spleen or intestine when wild-type OT-I or ∆E8 I OT-I CD8αβ + T cells were primed via the oral route (Fig. 3f) . Furthermore, there was also no selective accumulation of CD8αα-expressing wild-type OT-I CD8αβ IELs in TL − hosts (Fig. 3g) , which indicated that TL on the epithelial cells in the intestine imposed selective pressure to promote the local accumulation A r t i c l e s of CD8αα-expressing effector memory T cells. These data are consistent with a role for activation-induced CD8αα in sequestering TL away from the coreceptor CD8αβ, which thereby prevents TLinduced death of CD8αβ + primary effector T cells.
CD8aa marks the intensity of TCR activation
Because of the relatively high-affinity interaction of CD8αα with TL, activation-induced expression of CD8αα can be distinguished from CD8αβ expression through the use of TL tetramers 12 . Activated CD8αβ + T cells do not all induce CD8αα to the same extent, and a variegated expression pattern of high expression (CD8αα hi ) and low expression (CD8αα lo−neg ) is typically observed through the use of TL tetramers. Together with the fact that the initial induction of CD8αα requires TCR stimulation, this suggests that there might be a close link between the intensity of TCR activation and the degree of CD8αα induction. In support of that, TL tetramer staining of polyclonal CD8αβ + wild-type T lymphocytes activated in vitro with variable concentrations of soluble antibody to CD3 (anti-CD3) and anti-CD28 showed a graded increase in CD8αα expression with higher concentrations of anti-CD3 plus anti-CD28 (Fig. 4a) . Furthermore, OT-I T cells stimulated with various altered peptide ligands that bind as well to the H-2K b MHC class I molecule as does the original OT-I TCR ligand SIINFEKL but have different antigenic potencies 31 also demonstrated tight association between the extent of CD8αα induction and the degree of TCR activation. Thus, the original high-affinity ligand SIINFEKL induced higher CD8αα expression than did SIINFEKL variants with lower affinity (Fig. 4b) . We obtained results in vivo that also supported the idea of affinity-based induction of CD8αα when we analyzed mice infected orally with LM-OVA after they received either a high or low number of naive donor OT-I cells, which because of antigenic competition will result in either a low or high antigen dose, respectively (Fig. 4c) . Additionally, we analyzed two groups of recipient mice given adoptive transfer of an equal number of OT-I precursor cells but orally infected with L. monocytogenes expressing the low-affinity peptide variant SIIQFEKL (LM-Q4) or the high-affinity SIINFEKL peptide (LM-N4). Mice infected with LM-N4 generated more CD8αα-expressing CD8αβ + T cells than did those infected with LM-Q4 (Fig. 4d) . In each of these approaches, the results consistently indicated that the extent of CD8αα induction represents a sensitive measurement of the intensity of the signal strength received through the activated TCR. Similar to activation-induced expression of CD8αα, the expression of IL-7 receptor α-chain (IL-7Rα) also has been proposed as a marker for memory precursor cells 32 . However, in contrast to CD8αα expression, IL-7R expression did not correlate with TCR activation; instead, IL-7R was constitutively expressed on naive cells and was initially downregulated during activation at the time when CD8αα was first upregulated (Supplementary Fig. 3a) . The reciprocal expression of CD8αα and IL-7R suggested different roles for these molecules in memory programming and/or survival. Consistent with that hypothesis, a mutation in the sequence encoding the cytoplasmic IL-7Rα Y449XXM motif (where '449' indicates the position of the tyrosine residue and 'X' indicates any amino acid) known to impair the long-term survival of IL-7R-dependent CD8 + memory T cells 33 did not interfere with the induction of CD8αα or the survival and generation of OT-I memory T cells with this mutation in response to oral immunization with LM-OVA (Supplementary Fig. 3b ). These data indicated that the affinity-based selective programming of memory precursor cells does not depend on IL-7R signals. Overall, the data indicate that in addition to being a memory precursor marker 12 , CD8αα expression also 'reports on' the affinity or avidity of the antigen signal received by activated CD8αβ + primary effector cells. The affinity-based induction of CD8αα, together with the ability of CD8αα to sequester TL and prevent TL-induced cell death, therefore represents a mechanism by which the most avid CD8αβ + primary effector cells are selectively preserved as part of the memory precursor pool.
CD8aa marks human high-affinity CD8ab + T cells
Published evidence has indicated that tetramers of TL, in addition to detecting mouse CD8αα, also detect expression of human CD8αα homodimers 12, 17 . Consistent with activation-induced expression of CD8αα observed on mouse CD8 T cells, TL tetramers also stained human CD8αβ + effector cells, whereas they did not stain naive T cells (Fig. 5a) . Staining with the TL tetramer was blocked with an antibody specific for human CD8α but not by anti-CD8β ( Fig. 5b and Supplementary Fig. 4) , which confirmed the specificity of the TL tetramer for human CD8αα. Furthermore, a subset of high-affinity CD8αβ + T cells specific for the dominant epitope derived from the internal matrix protein pp65 of cytomegalovirus 34 , isolated from people seropositive for cytomegalovirus, stained almost exclusively with the TL tetramer, and this was blocked with anti-CD8α (Fig. 5c) . These data indicate that CD8αα expression on human CD8αβ + effector T cells also is associated with high-affinity effector cells.
Retinoic acid and transforming growth factor-b enhance CD8aa
The epithelium of the intestine is enriched for CD8αα-expressing CD8αβ + T cells, which suggests that a selective process based on CD8αα expression might drive this localized accumulation. Consistent with that, after priming in vitro, CD8αα expression on the activated T cells was higher after priming by mLN DCs than after priming by splenic DCs (Fig. 6a,b) . In the presence of exogenous retinoic acid, normally released by mLN DCs during priming 21 , splenic DCs also mediated strong induction of CD8αα on the OT-I T cells they primed (Fig. 6a,b) . Conversely, treatment with an inhibitor of the retinoic acid receptor resulted in lower CD8αα expression on T cells primed by mLN DCs (Fig. 6a) . Likewise, the addition of transforming growth factor-β (TGF-β), known to be an important modulator of mucosal T cell differentiation, resulted in more CD8αα induction on activated CD8αβ + primary effector cells primed by splenic DCs than on cells primed with splenic DCs alone (Fig. 6c) . However, we observed that in each condition, the enhanced induction of CD8αα occurred only in the presence of substantial antigen activation (Fig. 6b,c) , which suggested that they influenced CD8 + effector differentiation by further promoting the selective marking of high-affinity effector cells by CD8αα. The expression of TL on mucosal migratory DCs known to release retinoic acid and TGF-β (Fig. 1e,f) , together with the enhanced induction of CD8αα on high-affinity effectors in the presence of retinoic acid as well as TGF-β, indicated that the selective 'rescue' of high-affinity memory precursor cells was geared toward effector cells that home to the gut. In agreement with that, CD8αα-expressing OT-I cells were first detectable at mucosal induction sites, such as mLNs and Peyer's patches, early after oral exposure to antigen (Fig. 6d) . They then gradually accumulated during the contraction and memory phases in the pool of T EM cells positive for the integrin α E β 7 (CD103 + ) in the gut epithelium but not in the CD103 − memory cells that persisted systemically (Fig. 6e) .
TL on intestinal epithelium selects mature CD8ab T EM cells
The constitutive expression of TL on intestinal epithelial cells 15, 16 suggests that TL might continuously shape the resident mucosal memory CD8αβ + T cell population even after rechallenge. To investigate this possibility, we examined the fate of primary and secondary CD8αα hi CD8αβ + or CD8αα lo−neg CD8αβ + effector T cells in vivo. We initially primed OT-I cells in vitro in the absence of TL with APCs that do not naturally express TL, then sorted the cells into CD8αα hi and CD8αα lo−neg primary effector T cells and adoptively transferred them into wild-type recipient mice. Both subsets of primary effector cells showed a similar short-term homing ability ( Supplementary  Fig. 5a ), and both effector T cell types responded the same way when tested in vitro for interferon-γ production (Supplementary Fig. 5b ) or in vivo for cytotoxicity (Supplementary Fig. 5c ). However, in response to oral rechallenge with LM-OVA, primary memory OT-I T cell populations derived from the CD8αα hi precursor cells A r t i c l e s expanded in the spleens and intestines of wild-type recipient mice, whereas memory cells from the CD8αα lo−neg effector pool were detectable only in the host spleen but not in the intestine (Fig. 7a) . These data indicated that only CD8αα hi primary memory cells persisted long term as mucosal T EM cells in the proximity of TL constitutively expressed on the epithelial cells. After rechallenge, activated memory cell populations in lymphoid tissues expand and migrate as secondary effector cells to nonlymphoid tissues, such as the epithelium of the gut 35 . In agreement with that, similar numbers of effector cells derived from either CD8αα hi or CD8αα lo−neg primary effector OT-I cells were present in the intestine 5 d after recall (Fig. 7b) . Nevertheless, when analyzed 45 d later, the progeny of CD8αα hi effector cells were present as secondary memory cells in both the spleen and intestine, whereas the CD8αα lo−neg secondary effector cells did not remain as secondary T EM cells in the intestine (Fig. 7c) . In contrast, in vitro-primed CD8αα lo−neg CD8αβ + OT-I effector cells accumulated efficiently as T EM cells did in the gut epithelium of TL − recipient mice (Fig. 7d) , which indicated that the constitutive expression of TL continued to mediate selective pressure that prevented the accumulation of CD8αα lo−neg primary and secondary effector cells as mucosal T EM cells. These results also indicated that CD8αα lo−neg effector cells were not intrinsically unable to convert into mucosal T EM cells, but that under normal physiological conditions, only CD8αα hi primary effector cells formed long-lived mucosal T EM cells in proximity to TL constitutively expressed on the epithelial cells.
TL mediates the affinity maturation of memory CD8ab + T cells A published study using low-affinity altered peptide ligands for in vivo priming has suggested that the affinity maturation of memory T cells is the result of enhanced expansion and delayed contraction of the high-affinity responding effector cell populations 31 . Our results here suggested that in addition, the TL-mediated selective survival of CD8αα-expressing high-affinity memory cells might also contribute to ensuring the affinity maturation of memory populations at the mucosal border. To obtain direct evidence of this hypothesis, we used the altered-peptide-ligand approach of the published study noted above 31 to examine memory generation in vivo in the presence or absence of TL. We adoptively transferred naive OT-I cells into wild-type or TL − recipient mice that we subsequently orally infected with LM-Q4, which did not effectively induce CD8αα on primed OT-I effector cells (Fig. 4d) . Fewer OT-I effector cells were detectable in the blood of wild-type mice than in the blood of TL − mice at 7 d after oral immunization with LM-Q4 (Fig. 7e) , which suggested that TL induced on the priming mucosal APCs controlled in part the expansion of the primary effector pool. In the intestine, where TL is constitutively expressed by intestinal epithelial cells, the selective effect of TL was even greater. OT-I T EM cells generated in response to the low-affinity peptide Q4 were barely detectable in the intestinal epithelium of wild-type mice, whereas they were easily detectable in TL − mice (Fig. 7f) . These results indicated that continuous expression of TL on the epithelium of the intestine selectively eliminated low-affinity cells from the pool of mature mucosal T EM cells. Along with the greater mucosal memory in TL − mice, the systemic memory pool was also larger (Fig. 7f) , which suggested that in addition to the TL-mediated affinity selection of mature memory cells in the intestine, TL induced on mucosal APCs during priming might provide a first affinity-selection step by eliminating low-affinity or low-avidity primary effector cells from the memory precursor pool. To further test this idea, we immunized wildtype or TL − recipient mice with LM-Q4 via the intravenous route. Under these conditions, TL expression during priming had only a minimal effect on the effector or memory phase of peripheral T cells, which was similar in TL − and wild-type recipient mice (Fig. 7g,h ). In contrast, however, the accumulation of T EM cells at the mucosal site, where TL is constitutively expressed, remained under the TL selective pressure (Fig. 7h) . These results indicated that T cells primed at the mucosal priming site underwent an initial selection step mediated by TL induced on the migratory DCs, whereas, regardless of where the priming occurred, the constitutive expression of TL on the mucosal epithelium provided additional and constant selection pressure that drove continuous affinity maturation of the mature memory pool that accumulated long term at the mucosal interface of the intestine. (Supplementary Fig. 6 ) To evaluate the importance of preexisting TL-CD8αα-selected intestinal T EM cells, we assessed the resistance to oral infection with L. monocytogenes in mice with or without affinity-selected memory cells. For this, we transferred wild-type or ∆E8 I OT-I cells into mice that we then orally immunized with the attenuated ActA − LM-OVA strain (1 × 10 9 colony-forming units). We subsequently rechallenged the mice orally with a higher dose (1 × 10 10 colony-forming units) of wild-type LM-OVA and analyzed systemic spreading of the pathogen. In contrast to the efficient resistance observed in mice that received wild-type OT-I precursor cells, which generated memory cells in the intestine and elsewhere, preimmunized mice that initially received ∆E8 I OT-I precursor cells failed to generate affinity-selected memory and had significantly less resistance to systemic spreading of the orally introduced pathogen (Fig. 7i) . These results emphasize the importance of the selective immune memory differentiation process as a critical mechanism for the efficient generation of preexisting immunity at critical mucosal interfaces that form the main entry sites for invading pathogens.
DISCUSSION
The data presented here have defined a fundamentally new idea for the understanding of the mechanism of immune memory and in particular of the generation of mucosal immunity. Our data have demonstrated that an affinity-based selective process operates in vivo that preserves the optimal effector cells so they can become longlived memory T cells that form preexisting and heightened protective immunity. This mechanism is especially geared to generate the highaffinity T EM cells that line the mucosal barrier of the intestine, where most pathogens enter the body.
Our results have also demonstrated a function for TL, a nonclassical MHC class I-like molecule, in mediating TL-induced cell death of CD8αβ + effector T cells that failed to induce affinity-based CD8αα expression. Because TL is a much stronger ligand for CD8αα than for CD8αβ, CD8αα can probably sequester TL away from CD8αβ and prevent TL-induced cell death. As the induction of CD8αα was directly linked to the degree of TCR signal strength, this led to the selective survival of the most avid effector cells that then further differentiated into memory T cells. The constitutive expression of TL on the epithelial cells in the intestine continued selective pressure, which mediated affinity maturation of the mucosal T EM population in response to repeated rechallenge. 
A r t i c l e s
The data presented here obtained with the L. monocytogenes model are consistent with a published study using the LCMV model system, which has also indicated a critical role for activation-induced CD8αα in the generation of CD8αβ + memory T cells 12 . Nevertheless, two subsequent studies have challenged that conclusion and have provided evidence that under certain conditions, CD8αβ + ∆E8 I memory T cells can also be generated in a CD8αα-independent way 30, 36 . In those two studies 30, 36 , however, and similar to what we observed here with immunization with L. monocytogenes via the intravenous route, there was substantial downregulation of CD8αβ expression during the priming of the ∆E8 I CD8αβ + T cells, which was not observed in the earlier study with the LCMV system 12 or during oral immunization with the L. monocytogenes system, as shown here. The fact that in the absence of CD8αβ downregulation in both of those cases, ∆E8 I CD8αβ + T cells failed to accumulate as memory cells indicates that strong activation signals that result in downregulation of CD8αβ on ∆E8 I cells may 'rescue' CD8αβ + memory precursor cells, as does the biological activity of activation-induced CD8αα on normal wild-type CD8αβ + effector cells.
Although a sequence-based homolog of TL has not been identified in humans, TL and the nonclassical MHC class I molecule HLA-G have notable similarities, including their restricted pattern of expression, limited antigen-presentation ability, greater affinity for CD8αα than for CD8αβ and ability to induce the death of activated CD8αβ + T cells mediated by Fas and its ligand 25, 37, 38 . Such parallels suggest that like other nonclassical MHC or HLA pairs, TL and HLA-G might represent functional homologs of each other, and they further suggest that an affinity-based selective memory differentiation program probably operates in humans as well. Consistent with that, we found that activated human CD8αβ + T cells coexpressed CD8αα but naive cells did not, and that CD8αα expression coincided with the high-affinity CD8αβ + effector T cells specific for the dominant epitope pp65 of cytomegalovirus. Another study has indicated that the endogenous protective immune response to HIV is characterized by a CD8αα-expressing CD8αβ subpopulation with strong antiviral activity, and high-avidity HIV-specific CD8 + T cell clonotypes are largely preserved in patients who control HIV viremia but not in progressive chronic HIV infection 39 . Together these observations suggest that the induction of CD8αα on human CD8αβ + T cells is also an activation-induced and affinity-based process that marks the avid effector cells.
Most infections, not only infection with L. monocytogenes but also many viral infections such as infection with HIV or simian immunodeficiency virus, are acquired across mucosal barriers, and several studies have demonstrated that CD8 + cytotoxic T lymphocyte responses have a crucial role in the initial containment and early control of pathogen replication [40] [41] [42] [43] [44] . Although such responses may be unable to provide sterilizing protection, they can control the pathogen load and delay or even prevent spreading and the onset of disease, as well as diminish the potential for secondary transmission. Therefore, the finding that an endogenous TCR qualitybased mechanism may select for the most avid effector cells so they form immune memory cells able to reside long term at mucosal interfaces has important implications for the design of new and improved strategies to induce effective preexisting protective immunity, not only systemically but also locally at the main and most vulnerable entry sites for pathogens.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/natureimmunology/.
